Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1991 1
1998 1
2000 1
2008 3
2010 1
2011 4
2012 9
2013 3
2014 7
2015 6
2016 9
2017 1
2018 3
2019 3
2020 8
2021 9
2022 10
2023 7
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
Tiede A, Hart C, Knöbl P, Greil R, Oldenburg J, Sachs UJ, Miesbach W, Pfrepper C, Trautmann-Grill K, Holstein K, Pilch J, Möhnle P, Schindler C, Weigt C, Schipp D, May M, Dobbelstein C, Pelzer FJ, Werwitzke S, Klamroth R. Tiede A, et al. Among authors: holstein k. Lancet Haematol. 2023 Nov;10(11):e913-e921. doi: 10.1016/S2352-3026(23)00280-6. Epub 2023 Oct 16. Lancet Haematol. 2023. PMID: 37858328 Clinical Trial.
Tyrosine-protein kinase Yes controls endothelial junctional plasticity and barrier integrity by regulating VE-cadherin phosphorylation and endocytosis.
Jin Y, Ding Y, Richards M, Kaakinen M, Giese W, Baumann E, Szymborska A, Rosa A, Nordling S, Schimmel L, Akmeriç EB, Pena A, Nwadozi E, Jamalpour M, Holstein K, Sáinz-Jaspeado M, Bernabeu MO, Welsh M, Gordon E, Franco CA, Vestweber D, Eklund L, Gerhardt H, Claesson-Welsh L. Jin Y, et al. Among authors: holstein k. Nat Cardiovasc Res. 2022 Dec 7;1(12):1156-1173. doi: 10.1038/s44161-022-00172-z. Nat Cardiovasc Res. 2022. PMID: 37936984 Free PMC article.
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A.
Hart C, Klamroth R, Sachs UJ, Greil R, Knoebl P, Oldenburg J, Miesbach W, Pfrepper C, Trautmann-Grill K, Pekrul I, Holstein K, Eichler H, Weigt C, Schipp D, Werwitzke S, Tiede A. Hart C, et al. Among authors: holstein k. J Thromb Haemost. 2024 Oct;22(10):2692-2701. doi: 10.1016/j.jtha.2024.06.010. Epub 2024 Jun 25. J Thromb Haemost. 2024. PMID: 38936699 Free article.
Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia A.
Holstein K, Albisetti M, Bidlingmaier C, Halimeh S, Heine S, Klamroth R, Königs C, Kurnik K, Male C, Oldenburg J, Streif W, Wermes C, Escuriola-Ettingshausen C; ‘Ständige Kommission Hämophilie’ (Haemophilia board) of the German, Swiss Austrian Society for Thrombosis Haemostasis Research (GTH). Holstein K, et al. Hamostaseologie. 2020 Dec;40(5):561-571. doi: 10.1055/a-1127-6476. Epub 2020 Jun 25. Hamostaseologie. 2020. PMID: 32588417 Review.
Relationship between haemophilia and social status.
Holstein K, Eifrig B, Langer F. Holstein K, et al. Thromb Res. 2014 Nov;134 Suppl 1:S53-6. doi: 10.1016/j.thromres.2013.10.012. Epub 2014 Apr 13. Thromb Res. 2014. PMID: 24726554 Review.
Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions.
Blatný J, Astermark J, Catarino C, Dolan G, Fijnvandraat K, Hermans C, Holstein K, Jiménez-Yuste V, Klamroth R, Lavin M, Lenting PJ, Lobet S, Mancuso ME, Motwani J, O'Donnell JS, Königs C. Blatný J, et al. Among authors: holstein k. Ther Adv Hematol. 2024 Sep 30;15:20406207241285143. doi: 10.1177/20406207241285143. eCollection 2024. Ther Adv Hematol. 2024. PMID: 39381602 Free PMC article. Review.
83 results